Back
Sarepta Therapeutics Vs. Envestnet Industry Stock Comparison
Buy
52
SRPT
Sarepta Therapeutics
Last Price:
128.81
Seasonality Move:
13.16%
Buy
70
ENV
Envestnet
Last Price:
62.82
Seasonality Move:
8.6%
Buy
52
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $128.80. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Envestnet (ENV)
is a Buy
Is Envestnet a Buy, Sell or Hold?
- The current Envestnet [ENV] share price is $62.79. The Score for ENV is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- ENV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $128.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.
ENV Stock Price Chart
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 61.99 | Buy |
| Chaikin Money Flow: | -291612 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.47 - 128.97) | Buy |
| Bollinger Bands (100): | (102.98 - 131.42) | Buy |
ENV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.88 | Buy |
| Relative Strength Index (14 RSI): | 64.86 | Buy |
| Chaikin Money Flow: | 86605 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.11 - 61.95) | Buy |
| Bollinger Bands (100): | (47.72 - 57.82) | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.91 | Buy |
| 20-day SMA: | 123.06 | Buy |
| 50-day SMA: | 126.08 | Buy |
| 200-day SMA: | 111.7 | Buy |
| 8-day EMA: | 124.31 | Buy |
| 20-day EMA: | 123.46 | Buy |
| 50-day EMA: | 122.91 | Buy |
| 200-day EMA: | 116.14 | Buy |
ENV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.43 | Buy |
| 20-day SMA: | 60.1 | Buy |
| 50-day SMA: | 56.19 | Buy |
| 200-day SMA: | 50.02 | Buy |
| 8-day EMA: | 62.04 | Buy |
| 20-day EMA: | 60.37 | Buy |
| 50-day EMA: | 57.1 | Buy |
| 200-day EMA: | 52.61 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.72 per share, an increase next quarter of $3.22 per share, an increase this year of $5.19 per share, and an increase next year of $7.23 per share.
Envestnet Earnings Growth & ENV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.48 per share.
Sarepta Therapeutics Technical Analysis
| Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Envestnet Technical Analysis
| Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||